Target intelligence / Profile preview

Prolyl 3-hydroxylase OGFOD1 (OGFOD1)

Target
OGFOD1
Molecular classification
Enzyme, 2-oxoglutarate (2OG)-dependent oxygenase, Prolyl hydroxylase, Iron-dependent oxygenase
01

Overview

Prolyl 3-hydroxylase OGFOD1 is a conserved, iron and 2-oxoglutarate-dependent enzyme that catalyzes the post-translational hydroxylation of Pro62 in the small ribosomal subunit protein S23 (RPS23/uS12). This modification regulates the accuracy and efficiency of translation termination, and impacts cellular proliferation, stress granule formation, and autophagy. OGFOD1 is part of the broad family of 2OG-dependent oxygenases, sharing structural similarity to hypoxia-inducible factor prolyl hydroxylases; its activity is sensitive to iron chelators and oxygenase inhibitors. Loss or inhibition of OGFOD1 results in decreased RPS23 hydroxylation, reduced translation, context-dependent growth arrest, and altered mRNA splicing, with implications for cancer, cardiac biology, and stress adaptation. OGFOD1's unique role in ribosome function distinguishes it among the oxygenase family, and it is considered a therapeutic and research target for modulation of translation and stress pathways.

Other names
2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1KIAA1612TPA1FLJ10826Termination and polyadenylation 1 homologuS12 prolyl 3-hydroxylase
02

Mechanism of action

Inhibition of OGFOD1 reduces prolyl hydroxylation of ribosomal protein RPS23, leading to translational arrest, reduced protein synthesis, stress granule formation, and downstream cellular stress responses. Inhibition can also lead to altered splicing patterns by reducing translation of specific splicing regulators

03

Biological functions

Post-translational modification: catalyzes 3-hydroxylation of prolyl residue in ribosomal protein RPS23Regulation of protein translation and translation terminationResponse to cellular stress (e.g., formation of stress granules, regulation of eIF2α phosphorylation, modulation of autophagy)Influences cell proliferation and growth arrestRegulation of alternative splicing via its impact on translation of splicing factors
04

Disease associations

Cancer (role in altered translation, stress response, and cell proliferation)Heart failure (possible involvement in translational regulation during disease)Other (ribosome biology, protein synthesis regulation, stress responses)
05

Safety considerations

Inhibition may cause cell growth arrest and translational arrest, rather than apoptotic cell deathCell-type specificity: effects of OGFOD1 depletion vary between cell lines; some (e.g., HeLa) are relatively insensitivePotential for off-target effects when using broad-spectrum 2OG oxygenase inhibitors, since these may inhibit related enzymesImpairment of translation and alteration of alternative splicing, with possible impact on differentiation and proteome integrity
06

Interacting drugs

Dimethyloxalylglycine (DMOG)

4 more in the full profile.

07

Biomarkers

Hydroxylation status of RPS23 (Pro62)Phosphorylation level of eIF2α (as a marker of stress granule formation and translational stress)Presence of stress granules (G3BP1 localization)Expression and hydroxylation status of OGFOD1 itself (especially in disease contexts)

Beyond the preview

Go deeper on Prolyl 3-hydroxylase OGFOD1 (OGFOD1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolyl 3-hydroxylase OGFOD1 (OGFOD1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call